Partner Content Partner Content Juergen Knoebel from Roche speaks at the High Potent Medicin... Insights on HPAPI manufacturing
Events Partner Content The High Potent Medicines Conference The manufacturing of high potent medicines has provided many challenges in terms of safe production, containment and handling due to their toxic nature.
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
